CompletedPhase 2NCT01981551

Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis

Studying Desmoid tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Geraldine H O'Sullivan Coyne, M.D.
National Cancer Institute (NCI)
Intervention
PF-03084014(drug)
Enrollment
17 enrolled
Eligibility
18-120 years · All sexes
Timeline
2013 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01981551 on ClinicalTrials.gov

Other trials for Desmoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoid tumor →

← Back to all trials